Crossref
What can we learn from cannabinoid trials?
Age and Ageing · 04.09.2026 · 55 (9)
DOI: 10.1093/ageing/afag294 ↗Kurz gefasst
Fachartikel in der Zeitschrift Age and Ageing, online erschienen am 29.09.2026. Verfasst von Kaisu H Pitkälä und 1 weiteren Autor:innen. Beteiligte Einrichtung: Medical Faculty, University of Helsinki, PO BOX 20, 00014 Helsinki, Finland and Helsinki University Hospital, Unit of Primary Health Care, Helsinki, …. Die Arbeit nennt 15 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
agitationbehavioural disordercannabinoidsdementiaolder people
Autor:innen und Institutionen
- Medical Faculty, University of Helsinki, PO BOX 20, 00014 Helsinki, Finland and Helsinki University Hospital, Unit of Primary Health Care, Helsinki, Finland.
- Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
- Department of Geriatrics, Wellbeing County of Pirkanmaa, Tampere University Hospital, Tampere, Finland.
ORCID-Profile: Kaisu H Pitkälä, Hanna-Maria Roitto
Zitieren
APA
Pitkälä, K. H., & Roitto, H. M. (2026). What can we learn from cannabinoid trials?. Age and Ageing, 55(9). https://doi.org/10.1093/ageing/afag294
Vancouver
Pitkälä KH, Roitto HM. What can we learn from cannabinoid trials?. Age and Ageing. 2026;55(9). doi:10.1093/ageing/afag294
BibTeX
@article{Pitkl2026,
author = {Pitkälä, Kaisu H and Roitto, Hanna-Maria},
title = {What can we learn from cannabinoid trials?},
journal = {Age and Ageing},
year = {2026},
volume = {55},
number = {9},
doi = {10.1093/ageing/afag294}
}
EUVIMED